BackCellyan Biotechnology , Ltd Overview

Cellyan Biotechnology , Ltd Receivables

Cellyan Biotechnology , Ltd's receivables is $3.8M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$3.80M
↓ 19.45% YoYΔ $-916775.00 vs prior year quarter

Peer trimmed avg / median

Loading

Cellyan Biotechnology , Ltd Receivables History

Loading

Cellyan Biotechnology , Ltd vs. peers: Receivables Comparison

Loading

Cellyan Biotechnology , Ltd Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Cellyan Biotechnology , Ltd (HKPD) FAQ

As of the most recent data (March 2026), HKPD shows a receivables of $3.8M. That compares with $4.7M in the prior-year period — down 19.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HKPD's receivables is now $3.8M (was $4.7M) — a 19.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Cellyan Biotechnology , Ltd is outperforming or lagging.

Tracking HKPD's receivables over time shows whether Cellyan Biotechnology , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $3.8M That compares with $4.7M in the prior-year period — down 19.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Cellyan Biotechnology , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $3.8M) with ownership activity and broader fundamentals.